ArticleAnnals of medicine and surgery (2012)2024

Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma.

Nawal Khaliq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.